0000876661-22-000831.txt : 20221013
0000876661-22-000831.hdr.sgml : 20221013
20221013144546
ACCESSION NUMBER: 0000876661-22-000831
CONFORMED SUBMISSION TYPE: 25-NSE
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20221013
DATE AS OF CHANGE: 20221013
EFFECTIVENESS DATE: 20221013
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: Zymeworks Inc.
CENTRAL INDEX KEY: 0001403752
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38068
FILM NUMBER: 221308902
BUSINESS ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
BUSINESS PHONE: (604) 678-1388
MAIL ADDRESS:
STREET 1: SUITE 800 - 114 EAST 4TH AVENUE
CITY: Vancouver
STATE: A1
ZIP: V5T 1G4
FORMER COMPANY:
FORMER CONFORMED NAME: Zymeworks Inc
DATE OF NAME CHANGE: 20070620
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: NEW YORK STOCK EXCHANGE LLC
CENTRAL INDEX KEY: 0000876661
IRS NUMBER: 000000000
STATE OF INCORPORATION: NY
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
BUSINESS PHONE: 212-656-2060
MAIL ADDRESS:
STREET 1: 11 WALL STREET
CITY: NEW YORK
STATE: NY
ZIP: 10005
FORMER COMPANY:
FORMER CONFORMED NAME: NEW YORK STOCK EXCHANGE INC
DATE OF NAME CHANGE: 19910628
25-NSE
1
primary_doc.xml
X0203
0000876661
NEW YORK STOCK EXCHANGE LLC
0001403752
Zymeworks Inc.
001-38068
114 East 4th Avenue
Vancouver
Common Shares
17 CFR 240.12d2-2(a)(3)
Lauren Frawley
Analyst, Market Watch and Proxy Compliance
2022-10-13
EX-99.25
2
ruleprovisionnotice.htm
NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES
The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on October 24, 2022, pursuant to the provisions of Rule 12d2-2 (a).
[ X ] 17 CFR 240.12d2-2(a)(3) That on October 13, 2022 the instruments representing the securities comprising the entire class of this security came to evidence, by operation of law or otherwise, other securities in substitution therefore and represent no other right except, if such be the fact, the right to receive an immediate cash payment.
Pursuant to the change in country of incorporation and exchange of shares of Zymeworks Inc (Old). which became effective on October 13, 2022, each Common Share of Zymeworks Inc.(Old) was converted into either shares of common stock of Zymeworks Inc. (New) or exchangeable shares in the capital of Zymeworks ExchangeCo Ltd.
This Form 25 is only for the removal from listing on the NYSE of the Common Shares of Zymeworks Inc. (Old), and not a termination of the registrationof the Common Shares of Zymeworks Inc. (New) under Section 12(b) of the Exchange Act.
The Exchange also notifies the Securities and Exchange Commission that as a result of the above indicated conditions this security was suspended from trading on October 13, 2022.